InsidersTradesSigma
Follow the MARIZYME INC share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €40k. The latest transaction was disclosed on 20 April 2023 (Attribution). Among the most active insiders: Dhaduk Vithalbhai D. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
MARIZYME INC is a company listed on the XNAS market, specializing in the development of innovative therapeutic solutions. It focuses on the research and commercialization of products for the treatment of serious diseases.